Calcineurin and inflammatory signaling processes in aging and Alzheimer's Disease
Calcineurin and inflammatory signaling processes in aging and Alzheimer's Disease
批准号:
8297382
负责人:
Christopher Mark Norris
金额:
$30.03万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-01 至 2017-03-31
关键词:
APP-PS1AgeAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAnimalsAstrocytesAutomobile DrivingAvoidance LearningBehaviorBehavioralBiochemical ProcessBiological AssayBiological MarkersBrainBrain DiseasesCalcineurinCellsCeramicsCognitiveDataDependenceDependovirusDepositionDevelopmentDiseaseElectrodesElectrophysiology (science)Enzyme-Linked Immunosorbent AssayEnzymesFundingGene DeliveryGlial Fibrillary Acidic ProteinGlutamate ReceptorGlutamate TransporterGlutamatesHippocampus (Brain)HumanHypertrophyImpaired cognitionImplantIn VitroInflammatoryIpsilateralLabelMeasurementMeasuresMethodsMicroelectrodesMicrogliaMusNFAT PathwayNerve DegenerationNervous System PhysiologyNeurodegenerative DisordersNeurologic DysfunctionsOutcome MeasurePathologicPathologyPathway interactionsPhenotypeProcessProductionProtein phosphataseProteinsReactionRegulationResolutionRodent ModelRoleSignal TransductionSliceStagingSynapsesSynaptic plasticityTechniquesTestingTherapeuticTimeTissuesTransgenic MiceTransgenic OrganismsWestern BlottingWild Type Mouseadeno-associated viral vectoraging brainamyloid pathologyastrogliosisbasebeta-site APP cleaving enzyme 1computerized data processingcytokinefunctional outcomesimprovedin vivoinhibitor/antagonistinnovationinterestmouse modelneuroinflammationneuropathologyneuroprotectionnovel strategiespreventpromoterprotein expressionrelating to nervous systemresearch studyresponsesynaptic functiontranscription factortreatment strategyvector
中文摘要
描述(申请人提供):本项目中的实验使用创新的基因传递技术和多管齐下的方法来评估星形胶质细胞激活在阿尔茨海默病(AD)完整小鼠模型神经功能中的基础作用。研究使用携带星形胶质细胞特异性启动子Gfa2的腺相关病毒载体(AAV)靶向野生型和APP/PS1小鼠星形胶质细胞中的蛋白磷酸酶钙调神经磷酸酶(CN)和NFAT转录因子。AAV-Gfa2载体在不同年龄/疾病阶段双边输送到海马区,并对小鼠进行不同AD生物标志物的评估。在目标1中,认知状态通过主动回避任务来评估,而突触功能则通过海马片电生理学和突触蛋白的Western印迹测量来评估。在目标2中,使用陶瓷酶微电极阵列和谷氨酸转运体水平的测量来研究海马谷氨酸的调节。在目标3中,通过免疫组织化学(IHC)分析和使用多重ELISA评估细胞因子水平来确定神经胶质细胞激活和神经炎症的水平。在目标4中,使用IHC来确定A?ELISA用于定量可溶和不可溶的海马区组织中A?40和A?42的水平,Western ns用于评估BACE蛋白的表达。AAV-Gfa2载体编码CN/NFAT信号的有效抑制剂或激活剂,因此将决定这一星形细胞通路在驱动和/或维持AD小鼠神经功能障碍中的必要性和充分性。这些研究为研究激活的星形胶质细胞提供了一种非常新颖的方法,并可能对AD和其他神经退行性疾病的治疗策略的发展产生重大影响。
公共卫生相关性:越来越多的证据表明,激活的星形胶质细胞与各种神经退行性疾病有关,包括阿尔茨海默病(AD)。然而,这些细胞很难通过治疗选择性地靶向。在这个项目中,我们使用尖端的腺相关病毒载体选择性地阻止星形胶质细胞的激活,并改善完整的AD模型小鼠的神经功能。这种方法可能成为AD和其他神经退行性疾病的一种新的治疗策略。
英文摘要
DESCRIPTION (provided by applicant): The experiments in this project use innovative gene delivery techniques and a multipronged approach to assess the fundamental role of astrocyte activation in neurologic function in an intact mouse model of Alzheimer's disease (AD). Studies use adeno-associated virus vectors (AAV) bearing the astrocyte-specific promoter Gfa2 to target the protein phosphatase calcineurin (CN) and NFAT transcription factors in astrocytes of wild-type and APP/PS1 mice. AAV-Gfa2 vectors are bilaterally delivered to the hippocampus at different ages/disease stages and mice are assessed on different AD biomarkers. In Aim 1, cognitive status is assessed using the active avoidance task, while synaptic function is evaluated using hippocampal slice electrophysiology and Western blot measures of synaptic proteins. In Aim 2, hippocampal glutamate regulation is investigated using ceramic enzyme-based microelectrode arrays and measures of glutamate transporter levels. In Aim 3, levels of glial activation and neuroinflammation are determined with immunohistochemical (IHC) analyses and assessment of cytokine levels using Multiplex ELISAs. In Aim 4, IHC is used to determine the extent of A? deposition, while ELISAs are used to quantify levels of A?40 and A?42 in soluble and insoluble hippocampal tissue fractions, and Westerns used to assess BACE protein expression. AAV-Gfa2 vectors encode either potent inhibitors or activators of CN/NFAT signaling and therefore will determine the necessity and sufficiency of this astrocytic pathway in driving and/or maintaining neurologic dysfunction in AD mice. These studies provide a highly novel approach to the study of activated astrocytes and could have a major impact on the development of treatment strategies for AD and other neurodegenerative conditions.
PUBLIC HEALTH RELEVANCE: Increasing evidence implicates activated astrocytes in a variety of neurodegenerative conditions, including Alzheimer's disease (AD). However, these cells are difficult to target selectively with therapeutics. In this project, we use cutting-edge adeno associated virus vectors to selectively prevent astrocyte activation and improve neurologic function in intact AD model mice. This approach could emerge as a new treatment strategy for AD and other neurodegenerative disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Strategies for targeting astrocyte reactivity in Alzheimer's disease and related dementias.
-
批准号:10845083
-
项目类别:
-
资助金额:$38.08万
-
财政年份:2022
-
负责人:Christopher Mark Norris
-
依托单位:
Core A - Administrative Core
-
批准号:10907138
-
项目类别:
-
资助金额:$38.08万
-
财政年份:2022
-
负责人:Christopher Mark Norris
-
依托单位:
ROLE OF CALCINEURIN IN ASTROCYTE ACTIVATION ASSOCIATED WITH ALZHEIMER?S DISEASE
-
批准号:7610714
-
项目类别:
-
资助金额:$2.92万
-
财政年份:2007
-
负责人:Christopher Mark Norris
-
依托单位:
Calcineurin and inflammatory signaling processes in aging and Alzheimer's Disease
-
批准号:7458650
-
项目类别:
-
资助金额:$25.72万
-
财政年份:2006
-
负责人:Christopher Mark Norris
-
依托单位:
Calcineurin and inflammatory signaling processes in aging and Alzheimer's Disease
-
批准号:7890505
-
项目类别:
-
资助金额:$25.46万
-
财政年份:2006
-
负责人:Christopher Mark Norris
-
依托单位:
Calcineurin and inflammatory signaling processes in aging and Alzheimer's Disease
-
批准号:10531677
-
项目类别:
-
资助金额:$24.93万
-
财政年份:2006
-
负责人:Christopher Mark Norris
-
依托单位:
Calcineurin and inflammatory signaling processes in aging and Alzheimer's Disease
-
批准号:8657965
-
项目类别:
-
资助金额:$29.96万
-
财政年份:2006
-
负责人:Christopher Mark Norris
-
依托单位:
Calcineurin and inflammatory signaling processes in aging and Alzheimer's Disease
-
批准号:8825991
-
项目类别:
-
资助金额:$29.04万
-
财政年份:2006
-
负责人:Christopher Mark Norris
-
依托单位:
Calcineurin and inflammatory signaling processes in aging and Alzheimer's Disease
-
批准号:7643833
-
项目类别:
-
资助金额:$25.72万
-
财政年份:2006
-
负责人:Christopher Mark Norris
-
依托单位:
Calcineurin and inflammatory signaling processes in aging and Alzheimer's Disease
-
批准号:8442831
-
项目类别:
-
资助金额:$28.35万
-
财政年份:2006
-
负责人:Christopher Mark Norris
-
依托单位:
Calcineurin and inflammatory signaling processes in aging and Alzheimer's Disease
-
批准号:7145081
-
项目类别:
-
资助金额:$27.03万
-
财政年份:2006
-
负责人:Christopher Mark Norris
-
依托单位:
Calcineurin and inflammatory signaling processes in aging and Alzheimer's Disease
-
批准号:7282413
-
项目类别:
-
资助金额:$26.25万
-
财政年份:2006
-
负责人:Christopher Mark Norris
-
依托单位:
ROLE OF CALCINEURIN IN ASTROCYTE ACTIVATION ASSOCIATED WITH ALZHEIMER?S DISEASE
-
批准号:7382167
-
项目类别:
-
资助金额:$7.35万
-
财政年份:2006
-
负责人:Christopher Mark Norris
-
依托单位:
Calcineurin and Biobehavioral Markers of Brain Aging
-
批准号:7110134
-
项目类别:
-
资助金额:$8.59万
-
财政年份:2004
-
负责人:Christopher Mark Norris
-
依托单位:
Calcineurin and Biobehavioral Markers of Brain Aging
-
批准号:6944725
-
项目类别:
-
资助金额:$8.34万
-
财政年份:2004
-
负责人:Christopher Mark Norris
-
依托单位:
Calcineurin and Biobehavioral Markers of Brain Aging
-
批准号:7265092
-
项目类别:
-
资助金额:$8.85万
-
财政年份:2004
-
负责人:Christopher Mark Norris
-
依托单位:
Calcineurin and Biobehavioral Markers of Brain Aging
-
批准号:7463846
-
项目类别:
-
资助金额:$9.12万
-
财政年份:2004
-
负责人:Christopher Mark Norris
-
依托单位:
Calcineurin and Biobehavioral Markers of Brain Aging
-
批准号:6812797
-
项目类别:
-
资助金额:$8.1万
-
财政年份:2004
-
负责人:Christopher Mark Norris
-
依托单位:
CALCINEURIN IN CALCIUM CHANNEL REGULATION DURING AGING.
-
批准号:6657961
-
项目类别:
-
资助金额:$4.81万
-
财政年份:2002
-
负责人:Christopher Mark Norris
-
依托单位:
CALCINEURIN IN CALCIUM CHANNEL REGULATION DURING AGING.
-
批准号:6209799
-
项目类别:
-
资助金额:$3.75万
-
财政年份:2000
-
负责人:Christopher Mark Norris
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: